title: Recent aspirin use is associated with smaller myocardial infarct size and lower likelihood of Q-wave infarction.
abstract: BACKGROUND
  Controversy exists about the effect of recent aspirin use on infarct size and the likelihood of Q-wave infarction in patients who sustain myocardial infarction.
  
  
  METHODS
  We performed face-to-face interviews and chart reviews on 3665 patients with acute myocardial infarction for the Determinants of Myocardial Infarction Onset Study. For the 2206 patients who did not receive thrombolytic therapy, we assessed aspirin use, peak creatine kinase levels (in 1043 patients), and electrocardiographic interpretations (in 1447 patients).
  
  
  RESULTS
  Of the initial 1043 patients, 317 (30. 3%) subjects reported aspirin use in the 4 days before their infarction. The mean +/- SD peak creatine kinase level for aspirin users was 701 +/- 570 IU/mL versus 851 +/- 727 IU/mL for nonusers, an 18% difference (95% confidence interval [CI], 8% to 26%; P <.001). After adjustment for confounding factors, the difference was 12% (95% CI, 2% to 21%; P =.03). Similarly, 38.9% of the aspirin users and 48.7% of the nonusers sustained a Q-wave infarction, an odds ratio of 0.67 (95% CI, 0.54 to 0.83, P <.001). The adjusted odds ratio was 0.77 (95% CI, 0.61 to 0.97, P =.03).
  
  
  CONCLUSIONS
  Recent aspirin use was associated with smaller infarct size and fewer Q-wave infarctions among this population of early survivors of acute myocardial infarction who did not receive thrombolytic therapy.
authors.affiliation: Divisions of General Medicine and Primary Care and Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
authors.forename: K J
authors.initials: KJ
authors.lastname: Mukamal
authors.forename: M A
authors.initials: MA
authors.lastname: Mittleman
authors.forename: M
authors.initials: M
authors.lastname: Maclure
authors.forename: J B
authors.initials: JB
authors.lastname: Sherwood
authors.forename: R J
authors.initials: RJ
authors.lastname: Goldberg
authors.forename: J E
authors.initials: JE
authors.lastname: Muller
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D004796:Clinical Enzyme Tests / Q000706:statistics & numerical data; D016001:Confidence Intervals; D003402:Creatine Kinase / Q000097:blood / Q000187:drug effects; D004562:Electrocardiography / Q000187:drug effects* / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D007407:Interviews as Topic / Q000379:methods; D016014:Linear Models; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000517:prevention & control*; D016017:Odds Ratio; D012307:Risk Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D003402:Creatine Kinase; D001241:Aspirin